Selway Asset Management Bristol Myers Squibb CO Transaction History

Selway Asset Management

$239 Million
Q1 2025

A detailed history of Selway Asset Management transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Selway Asset Management holds 14,331 shares of BMY stock, worth $638,302. This represents 0.37% of its overall portfolio holdings.

Number of Shares

14,331

Previous 14,331 -0.0%

Holding current value

$638,302

Previous $810,000 7.9%

% of portfolio

0.37%

Previous 0.32%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	SELL	$51.92 - $59.94 $77,880 - $89,910	-1,500 Reduced 9.48%	14,331 $810,000
Q3 2024 Oct 10, 2024	SELL	$39.66 - $51.75 $836,825 - $1.09 Million	-21,100 Reduced 57.13%	15,831 $819,000
Q2 2024 Aug 13, 2024	SELL	$40.25 - $52.99 $122,158 - $160,824	-3,035 Reduced 7.59%	36,931 $1.53 Million
Q1 2024 Apr 10, 2024	SELL	$47.98 - $54.4 $52,778 - $59,840	-1,100 Reduced 2.68%	39,966 $2.17 Million
Q4 2023 Feb 07, 2024	SELL	$48.48 - $57.85 $265,088 - $316,323	-5,468 Reduced 11.75%	41,066 $2.11 Million
Q3 2023 Nov 02, 2023	BUY	$57.89 - $64.73 $5,904 - $6,602	102 Added 0.22%	46,534 $2.7 Million
Q3 2023 Oct 31, 2023	SELL	$57.89 - $64.73 $166,838 - $186,551	-2,882 Reduced 5.84%	46,432 $2.69 Million
Q2 2023 Jul 27, 2023	BUY	$63.71 - $70.74 $3,822 - $4,244	60 Added 0.12%	49,314 $3.15 Million
Q1 2023 May 10, 2023	BUY	$65.71 - $74.53 $262,840 - $298,120	4,000 Added 8.84%	49,254 $3.41 Million
Q4 2022 Feb 17, 2023	SELL	$68.48 - $81.09 $40,060 - $47,437	-585 Reduced 1.28%	45,254 $3.26 Million
Q3 2022 Nov 03, 2022	SELL	$0.13 - $76.84 $17 - $10,066	-131 Reduced 0.28%	45,839 $3.26 Million
Q2 2022 Aug 11, 2022	BUY	$72.62 - $79.98 $36,310 - $39,990	500 Added 1.1%	45,970 $3.54 Million
Q1 2022 Apr 11, 2022	SELL	$61.48 - $73.72 $202,884 - $243,276	-3,300 Reduced 6.77%	45,470 $3.32 Million
Q4 2021 Jan 19, 2022	SELL	$53.63 - $62.52 $10,726 - $12,504	-200 Reduced 0.41%	48,770 $3.04 Million
Q3 2021 Oct 21, 2021	BUY	$59.17 - $69.31 $16,271 - $19,060	275 Added 0.56%	48,970 $2.9 Million
Q2 2021 Jul 21, 2021	BUY	$61.91 - $67.42 $126,915 - $138,211	2,050 Added 4.39%	48,695 $3.25 Million
Q1 2021 Apr 26, 2021	BUY	$59.34 - $66.74 $241,810 - $271,965	4,075 Added 9.57%	46,645 $2.95 Million
Q4 2020 Feb 04, 2021	BUY	$57.74 - $65.43 $46,192 - $52,344	800 Added 1.92%	42,570 $2.64 Million
Q3 2020 Oct 28, 2020	BUY	$57.43 - $63.64 $534,099 - $591,852	9,300 Added 28.64%	41,770 $2.52 Million
Q2 2020 Jul 24, 2020	BUY	$54.82 - $64.09 $6,852 - $8,011	125 Added 0.39%	32,470 $1.91 Million
Q1 2020 Apr 22, 2020	BUY	$46.4 - $67.43 $39,440 - $57,315	850 Added 2.7%	32,345 $1.8 Million
Q4 2019 Jan 23, 2020	BUY	$49.21 - $64.19 $1.55 Million - $2.02 Million	31,495 New	31,495 $2.02 Million

Others Institutions Holding BMY

# of Institutions

2,662

Shares Held

1.64B

Call Options Held

22.4M

Put Options Held

25.4M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $94.7B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Selway Asset Management, based on Form 13F filings with the SEC.

News

Stay updated on Selway Asset Management with notifications on news.

Account

Selway Asset Management Bristol Myers Squibb CO Transaction History